Apeloa Pharmaceutical Co Ltd (000739) — Financial Flexibility Index
Apeloa Pharmaceutical Co Ltd (000739) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of CN¥612.91 Million (operating CF CN¥446.18 Million minus capex CN¥166.73 Million) represents 0% of total liabilities (CN¥5.97 Billion). Check 000739 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Apeloa Pharmaceutical Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Apeloa Pharmaceutical Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Apeloa Pharmaceutical Co Ltd.
Annual Financial Flexibility Index for Apeloa Pharmaceutical Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Apeloa Pharmaceutical Co Ltd. Explore 000739 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.27x | CN¥1.62 Billion | CN¥1.23 Billion | CN¥5.97 Billion | ▼ -3.0% |
| 2024 | 0.28x | CN¥1.67 Billion | CN¥1.21 Billion | CN¥5.98 Billion | ▲ +9.8% |
| 2023 | 0.25x | CN¥1.66 Billion | CN¥1.03 Billion | CN¥6.54 Billion | ▼ -9.9% |
| 2022 | 0.28x | CN¥1.84 Billion | CN¥1.33 Billion | CN¥6.50 Billion | ▼ -14.4% |
| 2021 | 0.33x | CN¥1.31 Billion | CN¥611.75 Million | CN¥3.98 Billion | ▼ -25.7% |
| 2020 | 0.44x | CN¥1.38 Billion | CN¥1.06 Billion | CN¥3.10 Billion | ▼ -12.2% |
| 2019 | 0.51x | CN¥1.39 Billion | CN¥1.36 Billion | CN¥2.75 Billion | ▲ +33.0% |
| 2018 | 0.38x | CN¥914.32 Million | CN¥832.69 Million | CN¥2.41 Billion | ▲ +168.9% |
| 2017 | 0.14x | CN¥373.22 Million | CN¥209.80 Million | CN¥2.64 Billion | ▼ -17.1% |
| 2016 | 0.17x | CN¥511.77 Million | CN¥180.42 Million | CN¥3.00 Billion | ▼ -43.2% |
| 2015 | 0.30x | CN¥893.23 Million | CN¥441.16 Million | CN¥2.98 Billion | ▼ -37.7% |
| 2014 | 0.48x | CN¥1.33 Billion | CN¥786.64 Million | CN¥2.76 Billion | ▲ +94.2% |
| 2013 | 0.25x | CN¥695.45 Million | CN¥190.45 Million | CN¥2.80 Billion | ▲ +0.6% |
| 2012 | 0.25x | CN¥675.49 Million | CN¥335.90 Million | CN¥2.74 Billion | ▼ -14.9% |
| 2011 | 0.29x | CN¥693.83 Million | CN¥404.62 Million | CN¥2.40 Billion | ▲ +15.0% |
| 2010 | 0.25x | CN¥260.85 Million | CN¥121.05 Million | CN¥1.04 Billion | ▼ -20.4% |
| 2009 | 0.32x | CN¥301.95 Million | CN¥208.30 Million | CN¥954.91 Million | ▼ -30.6% |
| 2008 | 0.46x | CN¥443.61 Million | CN¥94.57 Million | CN¥973.00 Million | ▲ +35.9% |
| 2007 | 0.34x | CN¥289.90 Million | CN¥174.20 Million | CN¥864.02 Million | ▲ +30.4% |
| 2006 | 0.26x | CN¥213.27 Million | CN¥159.43 Million | CN¥828.68 Million | ▼ -9.8% |
| 2005 | 0.29x | CN¥209.05 Million | CN¥87.40 Million | CN¥732.94 Million | ▲ +33.7% |
| 2004 | 0.21x | CN¥158.61 Million | CN¥47.54 Million | CN¥743.40 Million | ▼ -41.1% |
| 2003 | 0.36x | CN¥193.45 Million | CN¥105.36 Million | CN¥534.24 Million | ▲ +186.2% |
| 2002 | 0.13x | CN¥50.05 Million | CN¥2.81 Million | CN¥395.59 Million | ▲ +8937.8% |
| 2001 | 0.00x | CN¥458.70K | CN¥-569.79K | CN¥327.67 Million | ▼ -97.6% |
| 2000 | 0.06x | CN¥10.30 Million | CN¥7.08 Million | CN¥177.79 Million | ▲ +196.7% |
| 1999 | -0.06x | CN¥-12.72 Million | CN¥-20.52 Million | CN¥212.40 Million | ▼ -129.2% |
| 1998 | 0.20x | CN¥46.53 Million | CN¥30.10 Million | CN¥227.17 Million | — |